Fulgent Genetics, Inc. — Director's Dealing 2020

Mar 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Fulgent Genetics, Inc. (FLGT)
CIK: 0001674930
Period of Report: 2020-02-10

Reporting Person: KIM PAUL (CFO and Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-10	Common Stock	F	1325	$16.84	Disposed	438571	Direct
2020-02-25	Common Stock	G	1300	$0.00	Disposed	437271	Direct
2020-03-01	Common Stock	F	1612	$14.84	Disposed	435659	Direct

Footnotes

F1: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on August 10, 2016.

F2: Bona Fide Gift. No compensation was given to the donor for the gifting of shares.

F3: The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 27, 2019.